74 results
Page 3 of 4
8-K
EX-99.1
91dudhytea19md
10 Mar 21
Adicet Bio Announces Initiation of its First-in-Human Phase 1 Trial of ADI-001 for Company’s lead candidate, ADI-001, is believed to be the first IND-cleared allogeneic
7:30am
8-K
EX-1.1
mnlwpg69gqykq56th
16 Feb 21
Adicet Bio, Inc. Announces Proposed Public Offering of Common Stock and Concurrent Private Placement
4:01pm
424B5
xagh n18vhfu8p9
11 Feb 21
Prospectus supplement for primary offering
5:20pm
424B5
9tyfkpr em6mz
10 Feb 21
Prospectus supplement for primary offering
12:00am
424B5
of6wq50
1 Dec 20
Prospectus supplement for primary offering
5:28pm
8-K
EX-99.1
f030jexiy 2ca
22 Oct 20
Adicet Announces FDA Clearance of IND Application for First-in-Class Allogeneic CAR Gamma-Delta T Cell Therapy
7:15am
424B5
6mfxi cmwr4k1e
21 Sep 20
Prospectus supplement for primary offering
7:58am
8-K
EX-99.1
sr17 9qh4b8j
18 Sep 20
Management Following the Merger
4:30pm
8-K
EX-10.2
td5xb7 84eza
16 Sep 20
Entry into a Material Definitive Agreement
9:59am
8-K
EX-99.2
071f1se6g6obbt7
16 Sep 20
Entry into a Material Definitive Agreement
9:59am
8-K
EX-99.6
blzg45ykn qi
16 Sep 20
Entry into a Material Definitive Agreement
9:59am
8-K
EX-99.5
64veaufayjcz5kuc
16 Sep 20
Entry into a Material Definitive Agreement
9:59am
8-K
EX-10.13
7ft5 70b3j
16 Sep 20
Entry into a Material Definitive Agreement
9:59am
8-K
EX-99.1
66p6zf d9p
16 Sep 20
Entry into a Material Definitive Agreement
9:59am
8-K
EX-99.3
kgmi8uh9z15axll
16 Sep 20
Entry into a Material Definitive Agreement
9:59am
8-K
EX-99.4
iwrvce vkjva
16 Sep 20
Entry into a Material Definitive Agreement
9:59am
424B3
91f033o m4r62utih
21 Aug 20
Prospectus supplement
8:36am